5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3978-3987

  Horrillo, Raquel ^a   González Périz, Ana ^a   Martínez Clemente, Marcos ^a   López Parra, Marta ^a   Ferré, Natàlia ^a   Titos, Esther ^a,b   Morán Salvador, Eva ^a   Deulofeu, Ramon ^a   Arroyo, Vicente ^a,b   Clària, Joan ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; 2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; ADIPOCYTOKINE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEUKOTRIENE B4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; 5-LIPOXYGENASE-ACTIVATING PROTEIN; CARRIER PROTEIN; CYTOKINE; ICOSANOID; LIPID; MEMBRANE PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FATTY ACID TRANSPORT; FATTY LIVER; INFLAMMATION; INSULIN RESISTANCE; LIVER DISEASE; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

ADIPOSE TISSUE; ANIMALS; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DISEASE MODELS, ANIMAL; EICOSANOIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID METABOLISM; LIPIDS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NF-KAPPA B; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77951630780     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901355     Document Type: Article

References (34)

1. Wellen, K. E., and G. S. Hotamisligil. 2003. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112: 1785-1788.
2. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
3. Roden, M. 2006. Mechanisms of disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance. Nat. Clin. Pract. Endocrinol. Metab. 2: 335-348.
4. Angulo, P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346: 1221-1231.
5. Sanyal, A. J. 2005. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 46-53.
6. Samuelsson, B., S. E. Dahlén, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
7. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
8. Bäck, M., A. Sultan, O. Ovchinnikova, and G. K. Hansson. 2007. 5-Lipoxygenase- activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ. Res. 100: 946-949.
9. Kaaman, M., M. Rydén, T. Axelsson, E. Nordström, A. Sicard, A. Bouloumié, D. Langin, P. Arner, and I. Dahlman. 2006. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int. J. Obes. (Lond.) 30: 447-452.
10. Mehrabian, M., H. Allayee, J. Stockton, P. Y. Lum, T. A. Drake, L. W. Castellani, M. Suh, C. Armour, S. Edwards, J. Lamb, et al. 2005. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat. Genet. 37: 1224-1233.
11. Mehrabian, M., F. T. Schulthess, M. Nebohacova, L. W. Castellani, Z. Zhou, J. Hartiala, J. Oberholzer, A. J. Lusis, K. Maedler, and H. Allayee. 2008. Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia 51: 978-988.
12. López-Parra, M., E. Titos, R. Horrillo, N. Ferré, A. González-Périz, M. Martínez-Clemente, A. Planagumà, J. Masferrer, V. Arroyo, and J. Clària. 2008. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. J. Lipid Res. 49: 2513-2523.
13. Ho, M., S. Foxall, M. Higginbottom, D. M. Donofrio, J. Liao, P. J. Richardson, and Y. P. Maneuf. 2006. Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytes. Metabolism 55: 8-12. (Pubitemid 41736240)
14. Liao, J., R. Sportsman, J. Harris, and A. Stahl. 2005. Real-time quantification of fatty acid uptake using a novel fluorescence assay. J. Lipid Res. 46: 597-602. (Pubitemid 43109796)
15. Schwieterman, W., D. Sorrentino, B. J. Potter, J. Rand, C. L. Kiang, D. Stump, and P. D. Berk. 1988. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc. Natl. Acad. Sci. USA 85: 359-363.
16. Berk, P. D., S. Zhou, C. Kiang, D. D. Stump, X. Fan, and M. W. Bradbury. 1999. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J. Biol. Chem. 274: 28626-28631.
17. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez- Clemente, M. López-Parra, V. Arroyo, and J. Clària. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by v-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957.
18. Ferré, N., M. Martínez-Clemente, M. López-Parra, A. González-Périz, R. Horrillo, A. Planagumà, J. Camps, J. Joven, A. Tres, F. Guardiola, et al. 2009. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G553-G562.
19. Horrillo, R., A. Planagumà, A. González-Périz, N. Ferré, E. Titos, R. Miquel, M. López-Parra, J. L. Masferrer, V. Arroyo, and J. Clària. 2007. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor. J. Pharmacol. Exp. Ther. 323: 778-786.
20. Hui, Y., G. Yang, H. Galczenski, D. J. Figueroa, C. P. Austin, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and C. D. Funk. 2001. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J. Biol. Chem. 276: 47489-47495.
21. Sánchez-Galán, E., A. Gómez-Hernández, C. Vidal, J. L. Martín-Ventura, L. M. Blanco-Colio, B. Muñoz- García, L. Ortega, J. Egido, and J. Tuñón. 2009. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc. Res. 81: 216-225.
22. Bäck, M., D. X. Bu, R. Bränström, Y. Sheikine, Z. Q. Yan, and G. K. Hansson. 2005. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. USA 102: 17501-17506.
23. Ghosh, S., and M. S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8: 837-848.
24. Sun, B., and M. Karin. 2008. NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene. 27: 6228-6244.
25. Tilg, H., and A. R. Moschen. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6: 772-783.
26. Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114: 147-152.
27. Gowri, M. S., R. K. Azhar, F. B. Kraemer, G. M. Reaven, and S. Azhar. 2000. Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL. Am. J. Physiol. Endocrinol. Metab. 279: E593-600.
28. Long, Y. C., and J. R. Zierath. 2006. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116: 1776-1783.
29. Daval, M., F. Foufelle, and P. Ferré. 2006. Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. 574: 55-62. (Pubitemid 43905796)
30. Martin, V., P. Ronde, D. Unett, A. Wong, T. L. Hoffman, A. L. Edinger, R. W. Doms, and C. D. Funk. 1999. Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells. J. Biol. Chem. 274: 8597-8603.
31. Peres, C. M., D. M. Aronoff, C. H. Serezani, N. Flamand, L. H. Faccioli, and M. Peters-Golden. 2007. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. J. Immunol. 179: 5454-5461.
32. Lihn, A. S., N. Jessen, S. B. Pedersen, S. Lund, and B. Richelsen. 2004. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem. Biophys. Res. Commun. 316: 853-858.
33. Zhao, L., M. P. Moos, R. Gräbner, F. Pédrono, J. Fan, B. Kaiser, N. John, S. Schmidt, R. Spanbroek, K. Lötzer, et al. 2004. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10: 966-973.
34. Qiu, H., A. Gabrielsen, H. E. Agardh, M. Wan, A. Wetterholm, C. H. Wong, U. Hedin, J. Swedenborg, G. K. Hansson, B. Samuelsson, et al. 2006. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. USA 103: 8161-8166.